[Control of lymph-drainage tracts of the eye by the use of dalargin].
The objective was to study dalargin in experiment and its effect on drainage tracts in norm and with experimental hypertension, modulating secondary glaucoma. Investigations have been made on 82 rabbit eyes. The overall results show, that subconjunctival and electrophoretic dalargin injection of (0.1%-0.2-0.5 ml) causes the expansion of anterior and posterior lymph-drainage tracts of the eye and have hypotensive effect for ocular hypertension and secondary glaucoma.
Rapis
E G
EG
Tumanov
V P
VP
Levin
Iu M
IuM
Kurbanov
N Kh
NKh
D000818:Animals; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D005123:Eye / Q000187:drug effects*; D005901:Glaucoma / Q000188:drug therapy*; D008196:Lymph / Q000187:drug effects; D008208:Lymphatic System / Q000187:drug effects*; D009798:Ocular Hypertension / Q000188:drug therapy*; D011817:Rabbits; D013565:Sympatholytics / Q000494:pharmacology / Q000627:therapeutic use*
D013565:Sympatholytics; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Upravlenie limfodrenazhnymi putiami glaza s pomoshch'iu dalargina.